Stem Cell Therapy In Diabetic Foot Patients

Abstract

Background: The exploration of stem cell therapy in diabetic foot patients demonstrates a burgeoning field with significant potential for improving chronic wound healing associated with diabetes. The literature indicates a multifaceted understanding of various stem cell types, their mechanisms of action, and the clinical implications of their use. Literature Review: The article by (Gorecka et al., 2019) provides a foundational overview of induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs), highlighting their regenerative capabilities alongside challenges such as limited cell viability and the need for optimal delivery methods. This is crucial as diabetic foot ulcers (DFUs) often stem from impaired healing processes, making the regenerative properties of stem cells particularly relevant. Further, (Shafiee et al., 2021) reinforces the potential of umbilical cord blood-derived MSCs in DFUs, stressing the necessity for clinical trials to address safety and efficacy. The article indicates that while stem cell transplantation may enhance healing outcomes, ethical and procedural challenges hinder its practical application. Moreover, (Rai et al., 2022) elaborates on the mechanisms of angiogenesis linked to stem cell therapy, identifying critical factors that influence stem cell efficacy in hyperglycemic environments. The article suggests innovative strategies, such as biomaterial carriers and preconditioning of stem cells, to enhance therapeutic outcomes, addressing the common issue of compromised cell viability in diabetic conditions. Conclusion: In conclusion, the reviewed literature collectively underscores the promising potential of stem cell therapy for diabetic foot patients, while also identifying critical challenges such as cell viability, delivery methods, and the need for standardized treatment protocols. The ongoing research efforts aim to address these limitations, paving the way for more effective clinical appl